Lysosomal diseases: Overview on current diagnosis and treatment

45Citations
Citations of this article
129Readers
Mendeley users who have this article in their library.

Abstract

Lysosomal diseases (LDs), also known as lysosomal storage diseases (LSDs), are a heterogeneous group of conditions caused by defects in lysosomal function. LDs may result from deficiency of lysosomal hydrolases, membrane- associated transporters or other non-enzymatic proteins. Interest in the LD field is growing each year, as more conditions are, or will soon be treatable. In this article, we review the diagnosis of LDs, from clinical suspicion and screening tests to the identification of enzyme or protein deficiencies and molecular genetic diagnosis. We also cover the treatment approaches that are currently available or in development, including hematopoietic stem cell transplantation, enzyme replacement therapy, small molecules, and gene therapy.

Cite

CITATION STYLE

APA

Poswar, F., Vairo, F., Burin, M., Michelin-Tirelli, K., Brusius-Facchin, A., Kubaski, F., … Giugliani, R. (2019). Lysosomal diseases: Overview on current diagnosis and treatment. Genetics and Molecular Biology, 42(1), 165–177. https://doi.org/10.1590/1678-4685-gmb-2018-0159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free